Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07298434) titled 'Study of VYD2311 for the Prevention of COVID-19' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Invivyd, Inc.
Condition:
COVID-19
Intervention:
Drug: VYD2311-SD
Drug: VYD2311-MD
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: January 2026
Target Sample Size: 1770
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07298434
Publi...